Precision Continuous Renal Replacement Therapy and Solute Control

Sean M. Bagshaw, Madarasu Rajasekara Chakravarthi, Zaccaria Ricci, Ashita Tolwani, M. Neri, S. De Rosa, John A. Kellum, Claudio Ronco, ADQI Consensus Group

Research output: Contribution to journalArticle

Abstract

Continuous renal replacement therapy (CRRT) remains the dominant form of renal support among critically ill patients worldwide. Current clinical practice on CRRT prescription mostly relies on high quality studies suggesting no impact of CRRT dose on critically ill patients' outcomes. Recent clinical practice guidelines have been developed based on these studies recommending a static prescribed CRRT dose of 20-25 ml/kg/h. There is a rationale for renewed attention to CRRT prescription/practice based on the concept of dynamic solute control adapted to the changing clinical needs of critically ill patients. In response, Acute Disease Quality Initiative convened a 17th consensus meeting centered on re-evaluation of CRRT. This work group developed 4 themes focused specifically on CRRT dose prescription, delivery and solute control that were summarized in a series of consensus statements, along with the identification of critical knowledge gaps. CRRT dose prescription and delivery can be based on effluent flow rate. Delivered dose should be routinely monitored to ensure coherence with prescribed dose. CRRT dose should be dynamic, in recognition of between- and within-patient variation in targeted solute control or unintended solute clearance. Quality measures specific for monitoring delivered CRRT dose have been proposed that require further validation, prior to implementation, into the practice of guiding optimal CRRT dosage.

Original languageEnglish
Pages (from-to)238-247
Number of pages10
JournalBlood Purification
Volume42
Issue number3
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Renal Replacement Therapy
Prescriptions
Critical Illness
Acute Disease
Practice Guidelines
Kidney

Keywords

  • Acute kidney injury
  • Adequacy of CRRT
  • Continuous renal replacement therapy
  • CRRT dose
  • Dose
  • Intensity
  • Outcome
  • Precision CRRT
  • Quality
  • Solute control

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

Bagshaw, S. M., Chakravarthi, M. R., Ricci, Z., Tolwani, A., Neri, M., De Rosa, S., ... ADQI Consensus Group (2016). Precision Continuous Renal Replacement Therapy and Solute Control. Blood Purification, 42(3), 238-247. https://doi.org/10.1159/000448507

Precision Continuous Renal Replacement Therapy and Solute Control. / Bagshaw, Sean M.; Chakravarthi, Madarasu Rajasekara; Ricci, Zaccaria; Tolwani, Ashita; Neri, M.; De Rosa, S.; Kellum, John A.; Ronco, Claudio; ADQI Consensus Group.

In: Blood Purification, Vol. 42, No. 3, 01.09.2016, p. 238-247.

Research output: Contribution to journalArticle

Bagshaw, SM, Chakravarthi, MR, Ricci, Z, Tolwani, A, Neri, M, De Rosa, S, Kellum, JA, Ronco, C & ADQI Consensus Group 2016, 'Precision Continuous Renal Replacement Therapy and Solute Control', Blood Purification, vol. 42, no. 3, pp. 238-247. https://doi.org/10.1159/000448507
Bagshaw SM, Chakravarthi MR, Ricci Z, Tolwani A, Neri M, De Rosa S et al. Precision Continuous Renal Replacement Therapy and Solute Control. Blood Purification. 2016 Sep 1;42(3):238-247. https://doi.org/10.1159/000448507
Bagshaw, Sean M. ; Chakravarthi, Madarasu Rajasekara ; Ricci, Zaccaria ; Tolwani, Ashita ; Neri, M. ; De Rosa, S. ; Kellum, John A. ; Ronco, Claudio ; ADQI Consensus Group. / Precision Continuous Renal Replacement Therapy and Solute Control. In: Blood Purification. 2016 ; Vol. 42, No. 3. pp. 238-247.
@article{a0fbd83d762c436cbcb29720039b6c31,
title = "Precision Continuous Renal Replacement Therapy and Solute Control",
abstract = "Continuous renal replacement therapy (CRRT) remains the dominant form of renal support among critically ill patients worldwide. Current clinical practice on CRRT prescription mostly relies on high quality studies suggesting no impact of CRRT dose on critically ill patients' outcomes. Recent clinical practice guidelines have been developed based on these studies recommending a static prescribed CRRT dose of 20-25 ml/kg/h. There is a rationale for renewed attention to CRRT prescription/practice based on the concept of dynamic solute control adapted to the changing clinical needs of critically ill patients. In response, Acute Disease Quality Initiative convened a 17th consensus meeting centered on re-evaluation of CRRT. This work group developed 4 themes focused specifically on CRRT dose prescription, delivery and solute control that were summarized in a series of consensus statements, along with the identification of critical knowledge gaps. CRRT dose prescription and delivery can be based on effluent flow rate. Delivered dose should be routinely monitored to ensure coherence with prescribed dose. CRRT dose should be dynamic, in recognition of between- and within-patient variation in targeted solute control or unintended solute clearance. Quality measures specific for monitoring delivered CRRT dose have been proposed that require further validation, prior to implementation, into the practice of guiding optimal CRRT dosage.",
keywords = "Acute kidney injury, Adequacy of CRRT, Continuous renal replacement therapy, CRRT dose, Dose, Intensity, Outcome, Precision CRRT, Quality, Solute control",
author = "Bagshaw, {Sean M.} and Chakravarthi, {Madarasu Rajasekara} and Zaccaria Ricci and Ashita Tolwani and M. Neri and {De Rosa}, S. and Kellum, {John A.} and Claudio Ronco and {ADQI Consensus Group}",
year = "2016",
month = "9",
day = "1",
doi = "10.1159/000448507",
language = "English",
volume = "42",
pages = "238--247",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Precision Continuous Renal Replacement Therapy and Solute Control

AU - Bagshaw, Sean M.

AU - Chakravarthi, Madarasu Rajasekara

AU - Ricci, Zaccaria

AU - Tolwani, Ashita

AU - Neri, M.

AU - De Rosa, S.

AU - Kellum, John A.

AU - Ronco, Claudio

AU - ADQI Consensus Group

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Continuous renal replacement therapy (CRRT) remains the dominant form of renal support among critically ill patients worldwide. Current clinical practice on CRRT prescription mostly relies on high quality studies suggesting no impact of CRRT dose on critically ill patients' outcomes. Recent clinical practice guidelines have been developed based on these studies recommending a static prescribed CRRT dose of 20-25 ml/kg/h. There is a rationale for renewed attention to CRRT prescription/practice based on the concept of dynamic solute control adapted to the changing clinical needs of critically ill patients. In response, Acute Disease Quality Initiative convened a 17th consensus meeting centered on re-evaluation of CRRT. This work group developed 4 themes focused specifically on CRRT dose prescription, delivery and solute control that were summarized in a series of consensus statements, along with the identification of critical knowledge gaps. CRRT dose prescription and delivery can be based on effluent flow rate. Delivered dose should be routinely monitored to ensure coherence with prescribed dose. CRRT dose should be dynamic, in recognition of between- and within-patient variation in targeted solute control or unintended solute clearance. Quality measures specific for monitoring delivered CRRT dose have been proposed that require further validation, prior to implementation, into the practice of guiding optimal CRRT dosage.

AB - Continuous renal replacement therapy (CRRT) remains the dominant form of renal support among critically ill patients worldwide. Current clinical practice on CRRT prescription mostly relies on high quality studies suggesting no impact of CRRT dose on critically ill patients' outcomes. Recent clinical practice guidelines have been developed based on these studies recommending a static prescribed CRRT dose of 20-25 ml/kg/h. There is a rationale for renewed attention to CRRT prescription/practice based on the concept of dynamic solute control adapted to the changing clinical needs of critically ill patients. In response, Acute Disease Quality Initiative convened a 17th consensus meeting centered on re-evaluation of CRRT. This work group developed 4 themes focused specifically on CRRT dose prescription, delivery and solute control that were summarized in a series of consensus statements, along with the identification of critical knowledge gaps. CRRT dose prescription and delivery can be based on effluent flow rate. Delivered dose should be routinely monitored to ensure coherence with prescribed dose. CRRT dose should be dynamic, in recognition of between- and within-patient variation in targeted solute control or unintended solute clearance. Quality measures specific for monitoring delivered CRRT dose have been proposed that require further validation, prior to implementation, into the practice of guiding optimal CRRT dosage.

KW - Acute kidney injury

KW - Adequacy of CRRT

KW - Continuous renal replacement therapy

KW - CRRT dose

KW - Dose

KW - Intensity

KW - Outcome

KW - Precision CRRT

KW - Quality

KW - Solute control

UR - http://www.scopus.com/inward/record.url?scp=84988336200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988336200&partnerID=8YFLogxK

U2 - 10.1159/000448507

DO - 10.1159/000448507

M3 - Article

AN - SCOPUS:84988336200

VL - 42

SP - 238

EP - 247

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 3

ER -